Interested in our clinical trials for phenylketonuria (PKU) or homocystinuria (HCU)? Contact us at

The Point of

Synlogic is working at the intersection of biology and engineering,
pioneering the application of synthetic biology to design living
therapeutics programmed to treat disease in new ways.


Our Synthetic Biotics are novel biotherapeutics designed to address the underlying drivers of disease with the potential
to transform treatment paradigms and offer new hope to patients.

Realizing the Possibilities

Each day, our team comes to work excited by the challenge and opportunity to work at the forefront of a new field of medicine. We are driven by the promise of synthetic biology and by the new possibilities for better health that we believe we can bring to patients.